gardedam-therapeutics

Gardedam Therapeutics could name its drug after you! (If you donate enough to its crowdfunding effort)

Palo Alto biotech Gardedam Therapeutics is taking the crowdfunding route to raise $195,000 funding for its Parkinson’s and Alzheimer’s disease drug candidate. And it’s offering up perks like personal lab tours in Cambridge or Budapest, or the opportunity to rename a lead drug candidate to the donors that pony up more than $50,000. Donors at the […]

By Meghana Keshavan

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab